Research output per year
Research output per year
Personal profile
Education
- 2025 Ph.D, School of Pharmacy, Taipei Medical University
- 2016 M.S., Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2026- Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2025- Pharmacist, Department of Pharmacy, Taipei Medical University Hospital
- 2025- Certified Specialist of Genetic Cancer Risk Assessment, City of Hope, USA
- 2025- Professional Certificate of Pharmacogenomics, American Society of Health-System Pharmacists
- 2025- Chairperson, Membership Committee, American College of Clinical Pharmacy Taiwan Chapter
- 2021- Deputy Secretary-General, The Pharmacogenomics Society of Taiwan
- 2023- Deputy Chairperson, Committee of International Affairs, Taipei Pharmacists association
Research Interests
- Pharmacogenomics
- Cancer genomics
- Genetic risk assessment
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Wan-Hsuan Chou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Wdr4 regulates ribosome biogenesis and intestinal homeostasis via let-7
Kajal, K., Rastegari, E., Wang, W. D., Li, J. C., Chen, C. H., Chou, W. H., Chang, W. C., Lin, T. Y., Tsai, K., Lu, T. M., Venkatachalam, K. & Hsu, H. J., 2026, In: EMBO Reports. 27, 8, p. 1870-1903 34 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease
Hsu, S. W., Lin, M. R., Chou, W. H., Wan, Y. J. Y., Kao, W. Y. & Chang, W. C., Dec 2025, In: Cell and Bioscience. 15, 1, 131.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan
Chang, T. W., Chang, W. C., Chou, W. H., Chang, W. P. & Kuo, C. N., 2025, In: Journal of Food and Drug Analysis. 33, 2, p. 163-171 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Exploring the genomic and transcriptomic profiles of glycemic traits and drug repurposing
Lin, M. R., Tsai, C. L., Liao, C. S., Wei, C. Y., Chou, W. H., Hsiao, T. H. & Chang, W. C., Dec 2025, In: Journal of Biomedical Science. 32, 1, 50.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Genome-wide association study of hypersensitivity skin reactions induced by nonionic iodinated contrast media
Lin, M. R., Liu, T. Y., Hsu, H. Y., Hsieh, Y. W., Palupi, P. D., Chou, W. H., Lau, P. P., Chang, W. C. & Tsai, F. J., Sept 2025, In: Asian Pacific Journal of Allergy and Immunology. 43, 3, p. 590-603 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)